Agile_Logo-color on white.jpg
Agile Therapeutics Reports Third Quarter Financial Results
November 09, 2015 16:10 ET | Agile Therapeutics, Inc.
PRINCETON, N.J., Nov. 09, 2015 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women's health specialty pharmaceutical company focused on the development and commercialization of new...
Agile_Logo-color on white.jpg
Agile Therapeutics Announces Completion of Patient Enrollment in Twirla(R) Phase 3 SECURE Clinical Trial
October 19, 2015 16:08 ET | Agile Therapeutics, Inc.
PRINCETON, N.J., Oct. 19, 2015 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX) a women’s health specialty pharmaceutical company focused on the development and commercialization of...
Agile_Logo-color on white.jpg
Agile Therapeutics to Participate at FBR Second Annual Healthcare Conference
September 03, 2015 07:45 ET | Agile Therapeutics, Inc.
PRINCETON, N.J., Sept. 3, 2015 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (NASDAQ:AGRX), a women's health specialty pharmaceutical company focused on the development and commercialization of new...
Agile_Logo-color on white.jpg
Agile Therapeutics Announces Completion of Patient Recruitment in Twirla(R) Phase 3 SECURE Clinical Trial
August 31, 2015 16:05 ET | Agile Therapeutics, Inc.
PRINCETON, N.J., Aug. 31, 2015 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX) a women's health specialty pharmaceutical company focused on the development and commercialization of new...
Agile_Logo-color on white.jpg
Agile Therapeutics Reports Second Quarter Financial Results
August 13, 2015 16:05 ET | Agile Therapeutics, Inc.
PRINCETON, N.J., Aug. 13, 2015 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women's health specialty pharmaceutical company focused on the development and commercialization of new...
WCG logo
Evofem Announces the Completion of the Largest Phase III Contraceptive Clinical Trial to Date.
June 26, 2014 08:12 ET | WomanCare Global
SAN DIEGO, June 26, 2014 (GLOBE NEWSWIRE) -- Evofem announced the completion of the largest Phase III contraceptive clinical trial to date examining the efficacy of its contraceptive vaginal gel...
WeissLaw logo
Conceptus, Inc. Acquisition Investigation
April 29, 2013 13:12 ET | WeissLaw LLP
NEW YORK, April 29, 2013 (GLOBE NEWSWIRE) -- WeissLaw LLP, a national class action, shareholder rights law firm with offices in New York and Los Angeles, is examining possible breaches of fiduciary...